These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20682145)

  • 1. Contraceptive use among women with inflammatory bowel disease: A systematic review.
    Zapata LB; Paulen ME; Cansino C; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):72-85. PubMed ID: 20682145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraceptive safety among women with cystic fibrosis: a systematic review.
    Whiteman MK; Oduyebo T; Zapata LB; Walker S; Curtis KM
    Contraception; 2016 Dec; 94(6):621-629. PubMed ID: 27287694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive use among women with multiple sclerosis: a systematic review.
    Zapata LB; Oduyebo T; Whiteman MK; Houtchens MK; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):612-620. PubMed ID: 27452316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review.
    Godfrey EM; Whiteman MK; Curtis KM
    Contraception; 2013 May; 87(5):567-75. PubMed ID: 23044386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oral contraceptives and risk of ulcerative colitis - A systematic review and meta-analysis.
    Wang X; Fan X; Deng H; Zhang X; Zhang K; Xu J; Li N; Han Q; Liu Z
    Pharmacol Res; 2019 Jan; 139():367-374. PubMed ID: 30502529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When can a woman start combined hormonal contraceptives (CHCs)? A systematic review.
    Brahmi D; Curtis KM
    Contraception; 2013 May; 87(5):524-38. PubMed ID: 23153903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review.
    Culwell KR; Curtis KM; Del Carmen Cravioto M
    Obstet Gynecol; 2009 Aug; 114(2 Pt 1):341-353. PubMed ID: 19622996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease.
    Zitomersky NL; Levine AE; Atkinson BJ; Harney KM; Verhave M; Bousvaros A; Lightdale JR; Trenor CC
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):343-7. PubMed ID: 23752078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies.
    Ortizo R; Lee SY; Nguyen ET; Jamal MM; Bechtold MM; Nguyen DL
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1064-1070. PubMed ID: 28542115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient understanding of oral contraceptive pill instructions related to missed pills: a systematic review.
    Zapata LB; Steenland MW; Brahmi D; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):674-84. PubMed ID: 23040136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy.
    Nilsson LO; Victor A; Kral JG; Johansson ED; Kock NG
    Contraception; 1985 Feb; 31(2):195-204. PubMed ID: 3921310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
    Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missed hormonal contraceptives: new recommendations.
    Guilbert E; Black A; Dunn S; Senikas V; ;
    J Obstet Gynaecol Can; 2008 Nov; 30(11):1050-1062. PubMed ID: 19126288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of contraceptive use among women with congenital heart disease: A systematic review.
    Abarbanell G; Tepper NK; Farr SL
    Congenit Heart Dis; 2019 May; 14(3):331-340. PubMed ID: 30681774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases.
    Gawron LM; Goldberger A; Gawron AJ; Hammond C; Keefer L
    Inflamm Bowel Dis; 2014 Oct; 20(10):1729-33. PubMed ID: 25105949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis.
    Cornish JA; Tan E; Simillis C; Clark SK; Teare J; Tekkis PP
    Am J Gastroenterol; 2008 Sep; 103(9):2394-400. PubMed ID: 18684177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
    Visser J; Snel M; Van Vliet HA
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003990. PubMed ID: 17054193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.